Some specific targets and pathways were mainly enriched in the c2.all.v6.2.entrez.gmt gene set (Figure 2F), suggesting that progression of MPM may partly be involved in the invasive pathways of breast cancer and pathways related to TCF21 and SMARCA2 targets. This evidence concerns the gene TCF21 and breast carcinoma.